Results 51 to 60 of about 1,899,013 (161)
Tricuspid Regurgitation Complicating Heart Failure: A Novel Clinical Entity
With the escalating incidence of heart failure, accurate diagnosis is paramount for tailored therapeutic interventions. The tricuspid valve, particularly tricuspid regurgitation, once relegated as the “forgotten valve”, has gained prominence due to ...
Rongyang Xi +3 more
doaj +1 more source
Background: Tricuspid regurgitation is a condition that affects 1.6 million patients in the United States and is independently associated with morbidity and mortality.
Mustafa Kurnaz +4 more
doaj +1 more source
Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan +6 more
wiley +1 more source
The prevalence of mitral (MR) and tricuspid regurgitation (TR), especially in heart failure (HF) populations, is high. However, the distinct role of atrioventricular valve diseases in HF, whether they are merely indicators of disease status or rather ...
Jonathan Curio +2 more
doaj +1 more source
ABSTRACT Background Transvenous lead extraction (TLE) for cardiac implantable electronic device infection has high procedural success, but with a 1‐year mortality approaching 25%. Potential mechanisms include septic embolization and persistent infected lead casts or “ghosts.” Percutaneous mechanical aspiration of lead‐related vegetations during TLE is ...
Haran Yogasundaram +12 more
wiley +1 more source
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz +7 more
wiley +1 more source
Over the past 2 decades, structural heart interventions–including procedures like transcatheter aortic valve replacement, transcatheter mitral or tricuspid valve replacement, and transcatheter edge-to-edge mitral or tricuspid valve repair–have emerged as
Francesca Maria Di Muro, MD +6 more
doaj +1 more source
ABSTRACT Background Managing non‐functional cardiac implantable electronic device (CIED) leads remains controversial. While extraction is standard for infection, it is unclear whether transvenous lead extraction (TLE) or lead abandonment (LA) provides superior outcomes for superfluous leads.
Karanjeet Chauhan +8 more
wiley +1 more source
Tricuspid transcatheter valve-in-valve: an alternative for high-risk patients
Tricuspid valve disease is not uncommon. Some patients with tricuspid valve disease require tricuspid replacement with bioprosthesis and, over time, may require re-interventions.
Gaia, Diego Felipe [UNIFESP] +3 more
core +1 more source
BACKGROUND: Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Miao, Lifu +9 more
core +1 more source

